name: Base of tongue and pharyngeal speech and language exercise therapy


name: Bolus control speech and language exercise therapy


name: Drooling control speech and language exercise therapy


name: Elicit phonation speech and language exercise therapy


name: Speech and language exercise therapy individual


name: Orofacial speech and language exercise therapy


name: Swallowing and positioning speech and language exercise therapy


name: Thermal stimulation speech and language exercise therapy


name: Anomia speech and language rehabilitation


name: Verbal apraxia speech and language rehabilitation


name: Dysarthia speech and language rehabilitation


name: Dysphagia speech and language rehabilitation


name: Intelligibility speech and language rehabilitation individual


name: Intelligibility speech and language rehabilitation group


name: Receptive speech and language rehabilitation individual


name: Undefined speech therapy narrative required


name: Undefined existing client home-visit with ICD diagnosis narrative required


name: Undefined new client in-office without ICD diagnosis narrative required


name: Non-specified minor surgical procedure reference code no charge


name: Autogenic education individual each 15 minutes


name: Behavior modification assistance individual each 15 minutes


name: Pradhamana nasya application and/or instruction each 15 minutes


name: Subcutaneous oxidative medicine administration each treatment


name: ELISA/ACT(R) Diagnostic Trichophyton Test Block each test


name: Sexual assault pregnancy risk education each additional 15 minutes


name: Undefined adjunct care order and/or referral with or without ICD diagnosis narrative required


name: Undefined aquatic activity modality narrative required


name: Nambudripad Allergy Elimination Technique (NAET)(TM) allergy recheck no charge


name: Mood management assistance individual each 15 minutes


name: Stress reduction assistance group each 60 minutes


name: Prenatal uterine bleeding reduction and/or stabilization initial 15 minutes


name: Postpartum uterine bleeding reduction and stabilization initial 60 minutes


name: Undefined family planning and/or genetic counseling narrative required


name: Subcutaneous two or more substance injection each injection


name: ELISA/ACT(R) Screening Dander Hair Feather Block each test


name: Fluid and/or electrolyte management each additional 15 minutes


name: Societal and/or environmental coping assistance individual each 15 minutes


name: Radiofrequency Therapy Systems, Angioplasty


name: Analyzers, Laboratory, Hematology, Cell Counting, Automated


name: Radiofrequency Therapy Systems, Tissue Ablation


name: Analyzers, Laboratory, Body Fluid, Nitrogen


name: Preparing and/or dispensing and/or training services with or without ICD diagnosis


name: Undefined preparing and/or dispensing and/or training narrative required


name: Oriental herb and/or natural substance preparation training individual each 15 minutes


name: Western herb and/or natural substance preparation training individual each 15 minutes


name: Homeopathic remedy preparation training individual each 15 minutes


name: Self-care training individual each 15 minutes


name: Lifestyle risk factor education individual


name: Multifamily psychotherapy each 15 minutes


name: Vaginal delivery out-of-hospital each delivery


name: elements of cancer genetics risk assessment and counseling


name: 24 spice profile solution with separate immunoglobulin E (IgE) profiles each item


name: 24 spice profile solution with separate immunoglobulin G4 (IgG4) profiles each item


name: Additives preservatives hypersensitivity up to 15 items


name: Additives preservatives hypersensitivity 16 to 30 items


name: Haptens toxic mineral hypersensitivity up to 12 items


name: Immunoglobulin E (IgE) for 100 vegetarian foods each item


name: Immunoglobulin E (IgE) for 96 general foods each item


name: Immunoglobulin G4 (IgG4) for 100 vegetarian foods each item


name: Immunoglobulin G4 (IgG4) for 96 general foods each item


name: Lymphocyte transformation, Allergen Solution


name: Medications hypersensitivity up to 15 items


name: Pokeweed mitogen hypersensitivity each item


name: Undefined allergen solution narrative required


name: Ethylene diamine tetra acetate (EDTA) each three grams


name: Intravenous therapeutic infusion initial infusion


name: Essential metabolic fatty acid analysis 44 metabolites each test


name: Total intestinal secretory immunoglobulin A (sIgA) each test


name: Allergy profile one to eight items each test


name: Intracutaneous allergy test immediate-type reaction sequential and incremental with substance(s) each test


name: Percutaneous allergy test immediate-type reaction sequential and incremental with substance(s) each test


name: Analyzers, Point-of-Care, Whole Blood, Gas/pH/Electrolyte


name: Imaging, Three-Dimensional, Computer Assisted


name: heparin-binding dimeric hypotensive factor


name: pigment epithelium-derived factor receptor


name: Electrical Impedance Body Composition Analyzers


name: Infrared Light Body Composition Analyzers


name: Warming Units, Blood/Intravenous Solution


name: ANALYZER, ION, HYDROGEN-ION (PH), BLOOD-PHASE, INDWELLING


name: Ventilators, Intensive Care, Adult, Negative-Pressure


name: Manual wheelchair accessory, headrest extension, each


name: Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation


name: Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator with hypothermic circulatory arrest


name: Anesthesia for direct coronary artery bypass grafting; without pump oxygenator


name: Anesthesia for procedures in lumbar region; diagnostic or therapeutic lumbar puncture


name: Anesthesia for bone marrow aspiration and/or biopsy, anterior or posterior iliac crest


name: Anesthesia for open procedures involving hip joint; revision of total hip arthroplasty


name: Anesthesia for second- and third-degree burn excision or debridement with or without skin grafting, any site, for total body surface area (TBSA) treated during anesthesia and surgery; less than 4% total body surface area


name: Anesthesia for second- and third-degree burn excision or debridement with or without skin grafting, any site, for total body surface area (TBSA) treated during anesthesia and surgery; between 4% and 9% of total body surface area


name: Anesthesia for second- and third-degree burn excision or debridement with or without skin grafting, any site, for total body surface area (TBSA) treated during anesthesia and surgery; each additional 9% total body surface area or part thereof (List separately in addition to code for primary procedure)


name: application of bilaminate skin substitute or neodermis 25 cm2


name: Escharotomy; each additional incision (List separately in addition to code for primary procedure)


name: Osteotomy, mandible, segmental; with genioglossus advancement


name: Repair of nasal vestibular stenosis (eg, spreader grafting, lateral nasal wall reconstruction)


name: Transmyocardial laser revascularization, by thoracotomy; performed at the time of other open cardiac procedure(s) (List separately in addition to code for primary procedure)


name: Endovascular placement of iliac artery occlusion device (List separately in addition to code for primary procedure)


name: Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (List separately in addition to code for primary procedure)


name: Placement of femoral-femoral prosthetic graft during endovascular aortic aneurysm repair (List separately in addition to code for primary procedure)


name: Open iliac artery exposure for delivery of endovascular prosthesis or iliac occlusion during endovascular therapy, by abdominal or retroperitoneal incision, unilateral (List separately in addition to code for primary procedure)


name: Open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful endovascular repair; tube prosthesis


name: Open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful endovascular repair; aorto-bi-iliac prosthesis


name: Open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful endovascular repair; aorto-bifemoral prosthesis


name: Harvest of upper extremity artery, 1 segment, for coronary artery bypass procedure, open


name: Collection of blood specimen from a completely implantable venous access device


name: Naso- or oro-gastric tube placement, requiring physician's skill and fluoroscopic guidance (includes fluoroscopy, image documentation and report)


name: Donor enterectomy (including cold preservation), open; from cadaver donor


name: Donor enterectomy (including cold preservation), open; partial, from living donor


name: Intestinal allotransplantation; from cadaver donor


name: Intestinal allotransplantation; from living donor


name: Small intestinal endoscopy, enteroscopy beyond second portion of duodenum, not including ileum; with transendoscopic stent placement (includes predilation)


name: Small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; with transendoscopic stent placement (includes predilation)


name: Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)


name: Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)


name: Proctosigmoidoscopy, rigid; with transendoscopic stent placement (includes predilation)


name: Sigmoidoscopy, flexible; with endoscopic ultrasound examination


name: Sigmoidoscopy, flexible; with transendoscopic ultrasound guided intramural or transmural fine needle aspiration/biopsy(s)


name: Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)


name: Laparoscopy, surgical; radical nephrectomy (includes removal of Gerota's fascia and surrounding fatty tissue, removal of regional lymph nodes, and adrenalectomy)


name: Laparoscopy, surgical; ureteroneocystostomy with cystoscopy and ureteral stent placement


name: Laparoscopy, surgical; ureteroneocystostomy without cystoscopy and ureteral stent placement


name: Cystourethroscopy; with treatment of ureteral stricture (eg, balloon dilation, laser, electrocautery, and incision)


name: Cystourethroscopy; with treatment of ureteropelvic junction stricture (eg, balloon dilation, laser, electrocautery, and incision)


name: Cystourethroscopy; with treatment of intra-renal stricture (eg, balloon dilation, laser, electrocautery, and incision)


name: Cystourethroscopy with ureteroscopy; with treatment of ureteral stricture (eg, balloon dilation, laser, electrocautery, and incision)


name: Cystourethroscopy with ureteroscopy; with treatment of ureteropelvic junction stricture (eg, balloon dilation, laser, electrocautery, and incision)


name: Cystourethroscopy with ureteroscopy; with treatment of intra-renal stricture (eg, balloon dilation, laser, electrocautery, and incision)


name: Cystourethroscopy, with ureteroscopy and/or pyeloscopy; diagnostic


name: Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with removal or manipulation of calculus (ureteral catheterization is included)


name: Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy (ureteral catheterization is included)


name: Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with biopsy and/or fulguration of ureteral or renal pelvic lesion


name: Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with resection of ureteral or renal pelvic tumor


name: Excision of extraparenchymal lesion of testis


name: Cryosurgical ablation of the prostate (includes ultrasonic guidance and monitoring)


name: Incision and drainage of vaginal hematoma; obstetrical/postpartum


name: Incision and drainage of vaginal hematoma; non-obstetrical (eg, post-trauma, spontaneous bleeding)


name: Removal or revision of sling for stress incontinence (eg, fascia or synthetic)


name: Endometrial ablation, thermal, without hysteroscopic guidance


name: Surgery of complex intracranial aneurysm, intracranial approach; carotid circulation


name: Surgery of complex intracranial aneurysm, intracranial approach; vertebrobasilar circulation


name: Reprogramming of programmable cerebrospinal shunt


name: Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc, reexploration, single interspace; each additional cervical interspace (List separately in addition to code for primary procedure)


name: Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and/or excision of herniated intervertebral disc, reexploration, single interspace; each additional lumbar interspace (List separately in addition to code for primary procedure)


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; without endoscopic cyclophotocoagulation


name: Destruction of localized lesion of choroid (eg, choroidal neovascularization); photodynamic therapy (includes intravenous infusion)


name: Replacement (including removal of existing device), osseointegrated implant, skull; with percutaneous attachment to external speech processor


name: Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; with contrast material(s)


name: Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences


name: Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) and further sequences


name: Magnetic resonance angiography, neck; with contrast material(s)


name: Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences


name: Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); with contrast material(s)


name: Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s), followed by contrast material(s) and further sequences


name: Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)


name: Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences


name: Computed tomographic angiography, upper extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s)


name: Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; with contrast material(s)


name: Magnetic resonance (eg, proton) imaging, any joint of upper extremity; with contrast material(s)


name: Magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s), followed by contrast material(s) and further sequences


name: Computed tomographic angiography, lower extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s)


name: Magnetic resonance (eg, proton) imaging, lower extremity other than joint; with contrast material(s)


name: Magnetic resonance (eg, proton) imaging, any joint of lower extremity; with contrast material(s)


name: Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material(s), followed by contrast material(s) and further sequences


name: Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences


name: Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing


name: Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation


name: Fetal biophysical profile; without non-stress testing


name: Proton treatment delivery; simple, with compensation


name: Fetal lung maturity assessment; fluorescence polarization


name: Fetal lung maturity assessment; lamellar body density


name: Prostate specific antigen (PSA); complexed (direct measurement)


name: Allergen specific IgG quantitative or semiquantitative test, each allergen


name: Beta 2 Glycoprotein I antibody test, each


name: Immunoassay for tumor antigen, qualitative or semiquantitative (eg, bladder tumor antigen)


name: Immunoassay for tumor antigen, quantitative; CA 15-3 (27.29)


name: Immunoassay for tumor antigen, quantitative; CA 19-9


name: Immunoassay for tumor antigen, quantitative; CA 125


name: Analysis for antibody to Rickettsia (bacteria)


name: Culture, bacterial; stool, aerobic, additional pathogens, isolation and presumptive identification of isolates, each plate


name: Culture, bacterial; quantitative, aerobic with isolation and presumptive identification of isolates, any source except urine, blood or stool


name: Culture, bacterial; quantitative, anaerobic with isolation and presumptive identification of isolates, any source except urine, blood or stool


name: Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate


name: Culture, fungi, definitive identification, each organism; mold


name: culture typing identification by nucleic acid probe


name: Culture, typing; identification by pulse field gel typing


name: Susceptibility studies, antimicrobial agent; enzyme detection (eg, beta lactamase), per enzyme


name: Virus isolation; centrifuge enhanced (shell vial) technique, includes identification with immunofluorescence stain, each virus


name: Infectious agent antigen detection by immunofluorescent technique; Herpes simplex virus type 2


name: Infectious agent antigen detection by immunofluorescent technique; influenza B virus


name: Infectious agent antigen detection by immunofluorescent technique; Parainfluenza virus, each type


name: Infectious agent antigen detection by immunofluorescent technique; Pneumocystis carinii


name: Infectious agent antigen detection by immunofluorescent technique; Rubeola


name: Infectious agent antigen detection by immunofluorescent technique, polyvalent for multiple organisms, each polyvalent antiserum


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Cryptococcus neoformans


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Entamoeba histolytica dispar group


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Entamoeba histolytica group


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Helicobacter pylori


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; hepatitis B surface antigen (HBsAg) neutralization


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Influenza, A or B, each


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; Shiga-like toxin


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; polyvalent for multiple organisms, each polyvalent antiserum


name: Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; direct probe(s) technique


name: Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; amplified probe(s) technique


name: Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, reverse transcriptase and protease regions


name: Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; first through 10 drugs tested


name: Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; each additional drug tested (List separately in addition to code for primary procedure)


name: Semen analysis; sperm presence and motility of sperm, if performed


name: Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use


name: Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use


name: Hepatitis B vaccine (HepB), adolescent, 2 dose schedule, for intramuscular use


name: Hemodialysis access flow study to determine blood flow in grafts and arteriovenous fistulae by an indicator method


name: Electrogastrography, diagnostic, transcutaneous; with provocative testing


name: Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis


name: Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)


name: Peripheral arterial disease (PAD) rehabilitation, per session


name: Sensory integrative techniques to enhance sensory processing and promote adaptive responses to environmental demands, direct (one-on-one) patient contact, each 15 minutes


name: Removal of devitalized tissue from wound(s), non-selective debridement, without anesthesia (eg, wet-to-moist dressings, enzymatic, abrasion, larval therapy), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session


name: Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes


name: Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes


name: Medical nutrition therapy; group (2 or more individual(s)), each 30 minutes


name: Visual function screening, automated or semi-automated bilateral quantitative determination of visual acuity, ocular alignment, color vision by pseudoisochromatic plates, and field of vision (may include all or some screening of the determination[s] for contrast sensitivity, vision under glare)


name: Anesthesia for Burn Excisions or Debridement Procedures


name: Endovascular repair of abdominal aortic aneurysm


name: Other Diagnostic Gastroenterology Procedures


name: Peripheral Arterial Disease Rehabilitation


name: Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)


name: Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)


name: AMBULANCE SERVICE, BASIC LIFE SUPPORT, NON-EMERGENCY TRANSPORT, (BLS)


name: Ambulance service, basic life support, emergency transport (bls-emergency)


name: Ambulance service, conventional air services, transport, one way (fixed wing)


name: Ambulance service, conventional air services, transport, one way (rotary wing)


name: Paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers


name: Fixed wing air mileage, per statute mile


name: Rotary wing air mileage, per statute mile


name: Sacral nerve stimulation test lead, each


name: EXTENSION DRAINAGE TUBING, ANY TYPE, ANY LENGTH, WITH CONNECTOR/ADAPTOR, FOR USE WITH URINARY LEG BAG OR UROSTOMY POUCH, EACH


name: LUBRICANT, INDIVIDUAL STERILE PACKET, FOR INSERTION OF URINARY CATHETER, EACH


name: Urinary catheter anchoring device, adhesive skin attachment, each


name: Urinary catheter anchoring device, leg strap, each


name: Ostomy belt with peristomal hernia support


name: Collagen dressing, sterile, size 16 sq. in. or less, each


name: Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each


name: Collagen dressing, sterile, size more than 48 sq. in., each


name: Collagen dressing wound filler, sterile, per 6 inches


name: Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing


name: Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing


name: Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing


name: WATER, DISTILLED, USED WITH LARGE VOLUME NEBULIZER, 1000 ML


name: Tracheostoma valve, including diaphragm, each


name: Replacement diaphragm/faceplate for tracheostoma valve, each


name: Filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each


name: Filter for use in a tracheostoma heat and moisture exchange system, each


name: Housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each


name: Adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each


name: Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each


name: Housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each


name: Filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each


name: Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie


name: Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries


name: HYPERBARIC OXYGEN UNDER PRESSURE, FULL BODY CHAMBER, PER 30 MINUTE INTERVAL


name: Fresh frozen plasma, donor retested, each unit


name: Walker, heavy duty, without wheels, rigid or folding, any type, each


name: Walker, heavy duty, wheeled, rigid or folding, any type


name: Commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each


name: AEROSOL COMPRESSOR, ADJUSTABLE PRESSURE, LIGHT DUTY FOR INTERMITTENT USE


name: Ultrasonic/electronic aerosol generator with small volume nebulizer


name: External defibrillator with integrated electrocardiogram analysis


name: Implantable neurostimulator radiofrequency receiver


name: Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver


name: Fda approved nerve stimulator, with replaceable batteries, for treatment of nausea and vomiting


name: Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)


name: Ambulatory traction device, all types, each


name: Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present


name: Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)


name: Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more)


name: Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care


name: Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans


name: PHYSICIAN SUPERVISION OF A PATIENT UNDER A MEDICARE-APPROVED HOSPICE (PATIENT NOT PRESENT) REQUIRING COMPLEX AND MULTIDISCIPLINARY CARE MODALITIES INVOLVING REGULAR PHYSICIAN DEVELOPMENT AND/OR REVISION OF CARE PLANS, REVIEW OF SUBSEQUENT REPORTS OF PATIENT STATUS, REVIEW OF LABORATORY AND OTHER STUDIES, COMMUNICATION (INCLUDING TELEPHONE CALLS) WITH OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE PATIENT'S CARE, INTEGRATION OF NEW INFORMATION INTO THE MEDICAL TREATMENT PLAN AND/OR ADJUSTMENT OF MEDICAL THERAPY, WITHIN A CALENDAR MONTH, 30 MINUTES OR MORE


name: Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)


name: Coordinated care fee, risk adjusted high, initial


name: Coordinated care fee, risk adjusted low, initial


name: Coordinated care fee, risk adjusted maintenance


name: Coordinated care fee, scheduled team conference


name: Coordinated care fee, physician coordinated care oversight services


name: Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]


name: BEHAVIORAL HEALTH SCREENING TO DETERMINE ELIGIBILITY FOR ADMISSION TO TREATMENT PROGRAM


name: ALCOHOL AND/OR DRUG SCREENING; LABORATORY ANALYSIS OF SPECIMENS FOR PRESENCE OF ALCOHOL AND/OR DRUGS


name: BEHAVIORAL HEALTH COUNSELING AND THERAPY, PER 15 MINUTES


name: ALCOHOL AND/OR DRUG SERVICES; GROUP COUNSELING BY A CLINICIAN


name: ALCOHOL AND/OR DRUG SERVICES; CASE MANAGEMENT


name: ALCOHOL AND/OR DRUG SERVICES; CRISIS INTERVENTION (OUTPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; SUB-ACUTE DETOXIFICATION (HOSPITAL INPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; ACUTE DETOXIFICATION (HOSPITAL INPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; SUB-ACUTE DETOXIFICATION (RESIDENTIAL ADDICTION PROGRAM INPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; ACUTE DETOXIFICATION (RESIDENTIAL ADDICTION PROGRAM INPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; SUB-ACUTE DETOXIFICATION (RESIDENTIAL ADDICTION PROGRAM OUTPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; ACUTE DETOXIFICATION (RESIDENTIAL ADDICTION PROGRAM OUTPATIENT)


name: ALCOHOL AND/OR DRUG SERVICES; AMBULATORY DETOXIFICATION


name: ALCOHOL AND/OR DRUG SERVICES; INTENSIVE OUTPATIENT (TREATMENT PROGRAM THAT OPERATES AT LEAST 3 HOURS/DAY AND AT LEAST 3 DAYS/WEEK AND IS BASED ON AN INDIVIDUALIZED TREATMENT PLAN), INCLUDING ASSESSMENT, COUNSELING; CRISIS INTERVENTION, AND ACTIVITY THERAPIES OR EDUCATION


name: ALCOHOL AND/OR DRUG SERVICES; MEDICAL/SOMATIC (MEDICAL INTERVENTION IN AMBULATORY SETTING)


name: BEHAVIORAL HEALTH; RESIDENTIAL (HOSPITAL RESIDENTIAL TREATMENT PROGRAM), WITHOUT ROOM AND BOARD, PER DIEM


name: BEHAVIORAL HEALTH; SHORT-TERM RESIDENTIAL (NON-HOSPITAL RESIDENTIAL TREATMENT PROGRAM), WITHOUT ROOM AND BOARD, PER DIEM


name: BEHAVIORAL HEALTH; LONG-TERM RESIDENTIAL (NON-MEDICAL, NON-ACUTE CARE IN A RESIDENTIAL TREATMENT PROGRAM WHERE STAY IS TYPICALLY LONGER THAN 30 DAYS), WITHOUT ROOM AND BOARD, PER DIEM


name: ALCOHOL AND/OR DRUG SERVICES; METHADONE ADMINISTRATION AND/OR SERVICE (PROVISION OF THE DRUG BY A LICENSED PROGRAM)


name: Alcohol and/or drug training service (for staff and personnel not employed by providers)


name: Alcohol and/or drug intervention service (planned facilitation)


name: Behavioral health outreach service (planned approach to reach a targeted population)


name: BEHAVIORAL HEALTH PREVENTION INFORMATION DISSEMINATION SERVICE (ONE-WAY DIRECT OR NON-DIRECT CONTACT WITH SERVICE AUDIENCES TO AFFECT KNOWLEDGE AND ATTITUDE)


name: BEHAVIORAL HEALTH PREVENTION EDUCATION SERVICE (DELIVERY OF SERVICES WITH TARGET POPULATION TO AFFECT KNOWLEDGE, ATTITUDE AND/OR BEHAVIOR)


name: ALCOHOL AND/OR DRUG PREVENTION PROCESS SERVICE, COMMUNITY-BASED (DELIVERY OF SERVICES TO DEVELOP SKILLS OF IMPACTORS)


name: ALCOHOL AND/OR DRUG PREVENTION ENVIRONMENTAL SERVICE (BROAD RANGE OF EXTERNAL ACTIVITIES GEARED TOWARD MODIFYING SYSTEMS IN ORDER TO MAINSTREAM PREVENTION THROUGH POLICY AND LAW)


name: Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment


name: Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)


name: Autologous cultured chondrocytes, implant


name: Negative pressure wound therapy electrical pump, stationary or portable


name: Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories


name: Speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device


name: Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access


name: Speech generating software program, for personal computer or personal digital assistant


name: Accessory for speech generating device, mounting system


name: Accessory for speech generating device, not otherwise classified


name: Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: NASAL PROSTHESIS, PROVIDED BY A NON-PHYSICIAN


name: Midfacial prosthesis, provided by a non-physician


name: ORBITAL PROSTHESIS, PROVIDED BY A NON-PHYSICIAN


name: Upper facial prosthesis, provided by a non-physician


name: Hemi-facial prosthesis, provided by a non-physician


name: AURICULAR PROSTHESIS, PROVIDED BY A NON-PHYSICIAN


name: Partial facial prosthesis, provided by a non-physician


name: NASAL SEPTAL PROSTHESIS, PROVIDED BY A NON-PHYSICIAN


name: Unspecified maxillofacial prosthesis, by report, provided by a non-physician


name: Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician


name: Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies


name: Platelets, leukocytes reduced, each unit


name: Platelets, irradiated, each unit administered


name: Platelets, leukocytes reduced, irradiated, each unit


name: Platelets, pheresis, each unit administered


name: Platelets, pheresis, leukocytes reduced, each unit


name: Platelets, pheresis, irradiated, each unit administered


name: Platelets, pheresis, leukocytes reduced, irradiated, each unit


name: Red blood cells, irradiated, each unit administered


name: Red blood cells, deglycerolized, each unit


name: Red blood cells, leukocytes reduced, irradiated, each unit


name: Infusion, plasma protein fraction (human), 5%, 50 ml


name: Plasma, cryoprecipitate reduced, each unit administered


name: Radioelements for brachytherapy, any type, each


name: Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes


name: Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes


name: REMOVAL OF SUTURES; BY A PHYSICIAN OTHER THAN THE PHYSICIAN WHO ORIGINALLY CLOSED THE WOUND


name: Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel


name: Donor lobectomy (lung) for transplantation, living donor


name: Islet cell tissue transplant from pancreas; allogeneic


name: Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation


name: Cord blood harvesting for transplantation, allogeneic


name: Cord blood-derived stem-cell transplantation, allogeneic


name: Chemodenervation of abductor muscle(s) of vocal cord


name: Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)


name: 5% dextrose and 0.45% normal saline, 1000 ml


name: SCINTIMAMMOGRAPHY (RADIOIMMUNOSCINTIGRAPHY OF THE BREAST), UNILATERAL, INCLUDING SUPPLY OF RADIOPHARMACEUTICAL


name: Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)


name: Resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event)


name: Home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem


name: Services provided in an urgent care center (list in addition to code for service)


name: AMNIOTIC MEMBRANE FOR SURGICAL RECONSTRUCTION, PER PROCEDURE


name: Carbohydrate deficient transferrin measurement


name: HCPCS Level II National Modifiers, Obsolete


name: Prophylaxis against gastrointestinal ulcer


name: Prophylaxis against postmenopausal osteoporosis


name: Serum procollagen type III N-terminal propeptide


name: Diastolic left ventricular internal diameter


name: Alpha Hydroxybutyrate Dehydrogenase Measurement


name: Heparin-induced platelet activation test


name: Prophylaxis against heart transplant rejection


name: Prophylaxis against liver transplant rejection


name: Prophylaxis against pancreas transplant rejection


name: Prophylaxis against renal transplant rejection


name: Prophylaxis against heart and lung transplant rejection


name: Prophylaxis against renal and pancreas transplant rejection


name: Apolipoprotein B/Apolipoprotein A-1 ratio


name: Prophylaxis against lung transplant rejection


name: transplantation matching referral center


name: Organ subdivision part_of relationship value


name: Synovial fluid of temporomandibular joint


name: Synovial fluid of right temporomandibular joint


name: Synovial fluid of left temporomandibular joint


name: Synovial fluid of right incudomallear joint


name: Synovial fluid of left incudomallear joint


name: Synovial fluid of right incudostapedial joint


name: Synovial fluid of left incudostapedial joint


name: Neuropsychology & Neurology (PsycINFO Cluster Term)


name: Occupational & Employment (PsycINFO Cluster Term)


name: Computer Applications (PsycINFO Subcluster Term)


name: Computers & Communication (PsycINFO Subcluster Term)


name: Education & Training (PsycINFO Subcluster Term)


name: Human Machine Systems & Engineering (PsycINFO Subcluster Term)


name: Computers & Media (PsycINFO Subcluster Term)


name: Antisocial Behavior & Behavior Disorders (PsycINFO Subcluster Term)


name: Disorder Characteristics (PsycINFO Subcluster Term)


name: Learning Disorders & Mental Retardation (PsycINFO Subcluster Term)


name: Physical & Psychosomatic Disorders (PsycINFO Subcluster Term)


name: Speech & Language Disorders (PsycINFO Subcluster Term)


name: Symptomatology (PsycINFO Subcluster Term)


name: Academic Learning & Achievement (PsycINFO Subcluster Term)


name: Educational Personnel & Administration (PsycINFO Subcluster Term)


name: Student Characteristics & Academic Environment (PsycINFO Subcluster Term)


name: Schools & Institutions (PsycINFO Subcluster Term)


name: Special Education (PsycINFO Subcluster Term)


name: Student Populations (PsycINFO Subcluster Term)


name: Teaching & Teaching Methods (PsycINFO Subcluster Term)


name: Educational Testing & Counseling (PsycINFO Subcluster Term)


name: Criminal Groups (PsycINFO Subcluster Term)


name: Criminal Offenses (PsycINFO Subcluster Term)


name: Criminal Rehabilitation (PsycINFO Subcluster Term)


name: Legal Personnel (PsycINFO Subcluster Term)


name: Legal Processes (PsycINFO Subcluster Term)


name: Assessment & Diagnosis (PsycINFO Subcluster Term)


name: Neurological Disorders (PsycINFO Subcluster Term)


name: Electrophysiology (PsycINFO Subcluster Term)


name: Neurological Intervention (PsycINFO Subcluster Term)


name: Neurosciences (PsycINFO Subcluster Term)


name: Employee, Occupational & Job Characteristics (PsycINFO Subcluster Term)


name: Occupational Groups (PsycINFO Subcluster Term)


name: Organizations & Organizational Behavior (PsycINFO Subcluster Term)


name: Personnel Management & Professional Personnel Issues (PsycINFO Subcluster Term)


name: Statistical Reliability & Validity (PsycINFO Subcluster Term)


name: Statistical Theory & Experimentation (PsycINFO Subcluster Term)


name: Academic Achievement & Aptitude Measures (PsycINFO Subcluster Term)


name: Attitude & Interest Measures (PsycINFO Subcluster Term)


name: Testing Methods (PsycINFO Subcluster Term)


name: Neuropsychological Measures (PsycINFO Subcluster Term)


name: Nonprojective Personality Measures (PsycINFO Subcluster Term)


name: Perceptual Measures (PsycINFO Subcluster Term)


name: Projective Personality Measures (PsycINFO Subcluster Term)


name: Alternative Therapies (PsycINFO Subcluster Term)


name: Behavior Modification & Therapy (PsycINFO Subcluster Term)


name: Treatment Facilities (PsycINFO Subcluster Term)


name: Treatment (General) (PsycINFO Subcluster Term)


name: Medical & Physical Treatment (PsycINFO Subcluster Term)


name: Psychotherapy (PsycINFO Subcluster Term)


name: Rehabilitation (PsycINFO Subcluster Term)


name: Neurotransmitters & Neuroregulators (PsycINFO Subcluster Term)


name: Design, Analysis & Interpretation (PsycINFO Subcluster Term)


name: Intelligence Measures (PsycINFO Subcluster Term)


name: Psychological Disorders (PsycINFO Subcluster Term)


name: Developmental Measures (PsycINFO Subcluster Term)


name: Hospitalization & Institutionalization (PsycINFO Subcluster Term)


name: Detox-B Adjuvant/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen


name: MAGE-12 peptide vaccine/Montanide ISA-51


name: Interleukin-2/MAGE-12 Peptide Vaccine/Montanide ISA-51


name: Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Paclitaxel


name: Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Topotecan


name: Interferon Alfa/Paclitaxel/Yttrium Y 90 Monoclonal Antibody CC49


name: gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide


name: gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide


name: Monoclonal antibody 11D10 anti-idiotype vaccine/Monoclonal antibody 3H1 anti-idiotype vaccine


name: Screening for malignant neoplasm of esophagus


name: Indium In 111 Monoclonal Antibody Bre-3/Yttrium Y 90 Monoclonal Antibody Bre-3


name: Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine


name: Cyclosporine/Yttrium Y 90 Monoclonal Antibody M170


name: Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody M170


name: Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody Lym-1


name: Cyclosporine/Yttrium Y 90 Monoclonal Antibody Lym-1


name: Autologous Dendritic Cells/Autologous Tumor Cell Vaccine/Sargramostim


name: Autologous Tumor Cell Vaccine/Interleukin-2


name: IDEC-In2B8/Rituximab/Yttrium Y 90 Ibritumomab Tiuxetan


name: Detox-B Adjuvant/RAS Peptide Cancer Vaccine


name: Bismuth Bi213 Monoclonal Antibody M195/Cytarabine/Filgrastim


name: GPI-0100/MUC-2-Globo H-KLH Conjugate Vaccine


name: Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21


name: Interleukin-12/PSA Prostate Cancer Vaccine


name: Interferon Alfa/Lymphokine-Activated Killer Cells


name: Interleukin-2/Montanide ISA-51/Telomerase: 540-548 Peptide Vaccine


name: Deionizer water purification system, for hemodialysis


name: Consensus Development Conferences as Topic


name: Controlled Clinical Trial [Publication Type]


name: Consensus Development Conferences, NIH as Topic


name: Octinoxate/Oxybenzone/Padimate O 4%-4.5%-8% Topical application Ointment


name: Avobenzone/Octocrylene 3%-10% Topical application Lotion


name: piperonyl butoxide-pyrethrins topical 3%-0.3% topical kit


name: syringe without needle,insulin disposable


name: hydroquinone/oxybenzone/padimate O 4 % TOPICAL CREAM (GRAM)


name: hydrocolloid dressing 4" X 3.6" TOPICAL BANDAGE


name: foam bandage 6 3/4" X 6 3/4" TOPICAL BANDAGE


name: hydrocolloid dressing 8" X 9" TOPICAL BANDAGE


name: Bio-Statin, 2000000000 units compounding powder


name: carbetapentane / guaifenesin / phenylephrine


name: carbinoxamine / hydrocodone / pseudoephedrine


name: acetaminophen / doxylamine / pseudoephedrine


name: Taraxacum officinale / dandelion homeopathic preparation


name: Solanum tuberosum, potato, Homeopathic preparation


name: Ranunculus bulbosus homeopathic preparation


name: Inadequate preparation: examination completed


name: Inadequate preparation: precluding a complete examination


name: Poor preparation as reason of limitation


name: Patient unstable as reason of limitation


name: Equipment malfunction as reason of limitation


name: Size of the extrinsic impression of the esophageal lumen


name: Type of previous endoscopic intervention of the papilla major


name: Type of previous endoscopic intervention on the papilla minor


name: Size of extrinsic impression of biliary system stenosis


name: Helicobacter Pylori test (as purpose of biopsy)


name: Type of removal of percutaneous gastrostomy


name: External removal of percutaneous gastrostomy


name: Internal removal of percutaneous gastrostomy


name: Injection purpose, eradication of varices


name: Reason for upper gastrointestinal endoscopy


name: Assessment as reason for upper g.i. examination


name: Preoperative assessment as reason for upper g.i. examination


name: Post-operative assessment as reason for upper g.i. examination


name: Screening as reason for upper g.i. examination


name: Abnormal imaging procedure as reason for upper g.i. examination


name: Reason type for disease as reason for upper g.i. examination


name: Suspected disease as reason for upper g.i. examination


name: Established disease as reason for upper g.i. examination


name: Exclusion of disease as reason for upper g.i. examination


name: Follow-up of disease as reason for upper g.i. examination


name: For therapy of disease as reason for upper g.i. examination


name: Reason for lower gastrointestinal endoscopy


name: Other symptom as reason for lower g.i. examination


name: Other disease as reason for lower g.i. examination


name: Assessment as reason for lower g.i. examination


name: Preoperative assessment as reason for lower g.i. examination


name: Post-operative assessment as reason for lower g.i. examination


name: Screening as reason for lower g.i. examination


name: Abnormal imaging procedure as reason for lower g.i. examination


name: Diagnostic sampling as reason for lower g.i. examination


name: Reason type for disease as reason for lower g.i. examination


name: Established disease as reason for lower g.i. examination


name: Exclusion of disease as reason for lower g.i. examination


name: Follow-up of disease as reason for lower g.i. examination


name: For therapy of disease as reason for lower g.i. examination


name: Preoperative assessment as reason for ERCP


name: Post-operative assessment as reason for ERCP


name: Reason type for disease as reason for ERCP


name: For therapy of disease as reason for ERCP


name: Other as other diagnosis for the esophagus


name: Reason type for main diagnosis for the esophagus


name: Established main diagnosis for the esophagus


name: Exclusion of main diagnosis for the esophagus


name: Follow-up of main diagnosis for the esophagus


name: For therapy of main diagnosis for the esophagus


name: Other as other diagnosis for the stomach


name: Reason type for main diagnosis for the stomach


name: Suspected main diagnosis for the stomach


name: Established main diagnosis for the stomach


name: Follow-up of main diagnosis for the stomach


name: For therapy of main diagnosis for the stomach


name: Other as other diagnosis for the duodenum


name: Reason type for main diagnosis for the duodenum


name: Suspected main diagnosis for the duodenum


name: Established main diagnosis for the duodenum


name: Exclusion of main diagnosis for the duodenum


name: Follow-up of main diagnosis for the duodenum


name: For therapy of main diagnosis for the duodenum


name: Reason type for main diagnosis for the colon


name: Established main diagnosis for the colon


name: Exclusion of main diagnosis for the colon


name: For therapy of main diagnosis for the colon


name: Other as other diagnosis for the pancreas


name: Reason type for main diagnosis for the pancreas


name: Suspected main diagnosis for the pancreas


name: Established main diagnosis for the pancreas


name: Exclusion of main diagnosis for the pancreas


name: Follow-up of main diagnosis for the pancreas


name: For therapy of main diagnosis for the pancreas


name: Reason type for main diagnosis for the biliary tract


name: Suspected main diagnosis for the biliary tract


name: Established main diagnosis for the biliary tract


name: Exclusion of main diagnosis for the biliary tract


name: Follow-up of main diagnosis for the biliary tract


name: Submucosal injection as duct cannulation result


name: Diagnostic sampling as reason for upper g.i. examination


name: Suspected disease as reason for lower g.i. examination


name: Suspected main diagnosis for the esophagus


name: Exclusion of main diagnosis for the stomach


name: Follow-up of main diagnosis for the colon


name: Other as other diagnosis for the biliary tract


name: For therapy of main diagnosis for the biliary tract


name: Date vaccine information statement published:Date:Pt:^Patient:Qn


name: Date vaccine information statement presented:Date:Pt:^Patient:Qn


name: Ammonium urate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF


name: Calcium oxalate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF


name: Calcium phosphate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF


name: Calcium sulfate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF


name: Oval fat bodies (globules):PrThr:Pt:Urine sed:Ord:Microscopy.light


name: Amikacin 8.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Amikacin 16.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Amikacin 32.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Amikacin 12.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Amikacin 6.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ciprofloxacin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ciprofloxacin 4.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethionamide 11.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Streptomycin 6.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Pyrazinamide 25.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ciprofloxacin 8.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ciprofloxacin 5.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Clarithromycin 8.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Clarithromycin 32.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethambutol 5.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethambutol 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethionamide 5.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethionamide 15.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Rifabutin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Rifabutin 4.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: rifAMPin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: rifAMPin 5.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Streptomycin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Streptomycin 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: cycloSERINE 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: cycloSERINE 20.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: cycloSERINE 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Capreomycin 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Capreomycin 20.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Capreomycin 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Kanamycin 6.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Kanamycin 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Para aminosalicylate 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Para aminosalicylate 8.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Isoniazid 0.1 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria


name: Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria


name: cefOXitin 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Imipenem 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Cefmetazole 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Erythromycin 15.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Minocycline 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: sulfiSOXAZOLE 300.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Tobramycin 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Vancomycin 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Pyrazinamide 100.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethambutol 2.5 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Ethionamide 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Streptococcus pneumoniae Danish serotype 6B Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 6B Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 6B Ab.IgG:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 7F Ab.IgG:MCnc:Pt:Ser:Qn


name: Parainfluenza virus 1 Ab^2nd specimen:Titr:Pt:Ser:SemiQn:Comp fix


name: Rubella virus Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn


name: Measles virus Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn


name: Toxoplasma gondii Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn


name: Amoxicillin+Clavulanate:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Taenia solium larva Ab.IgG:ACnc:Pt:Ser:Qn


name: Deprecated Budgerigar droppings IgE Ab RAST class in Serum


name: Campylobacter fetus Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Campylobacter jejuni Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: cefTRIAXone:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Coagulation calcium ion induced:Time:Pt:PPP^Control:Qn:Coag


name: Taenia solium larva Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Herpes virus 6 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Herpes virus 6 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Pinus radiata Ab.IgE.RAST class:PrThr:Pt:Ser:Ord


name: Pituitary glycoprotein hormone.alpha subunit:ACnc:Pt:Ser:Qn


name: Progesterone^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Progesterone^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Renin^1st specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Deprecated Budgerigar serum proteins IgE Ab RAST class in Serum


name: C peptide^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^14th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Calcium^5H post 500 mg calcium PO:SCnc:Pt:Urine:Qn


name: Deprecated Cortisol [Molecules/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM


name: Cortisol^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Deprecated Cortisol [Molecules/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM


name: Cortisol^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Deprecated Cortisol [Molecules/volume] in Serum or Plasma --pre 250 ug corticotropin IM


name: Follitropin^1.5H post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^1H post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^1st specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^30M post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^5th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^6th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^8th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Follitropin^9th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP


name: Gastrin^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Gastrin^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1H post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2H post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^2H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^3.5H post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Glucose^30M post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^4.5H post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^4H post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^5.5H post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Glucose^6H post dose glucose:SCnc:Pt:Ser/Plas:Qn


name: Glucose^1.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^pre 50 g glucose PO:SCnc:Pt:Ser/Plas:Qn


name: Insulin^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^14th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Ketones^1H post 50 g glucose PO:PrThr:Pt:Urine:Ord


name: Ketones^2H post dose glucose:MCnc:Pt:Urine:SemiQn:Test strip


name: Ketones^4H post dose glucose:MCnc:Pt:Urine:SemiQn:Test strip


name: Leptospira interrogans serovar Grippotyphosa Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Lutropin^1.5H post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^1H post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^2H post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^30M post 100 ug luteinizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^10M post 200 ug TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^20M post 200 ug TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^2H post 200 ug TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^30M post 200 ug TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^40M post 200 ug TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^50M post 200 ug TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Rheumatoid factor:PrThr:Pt:Body fld:Ord:Sheep cell aggl


name: Insulin-like growth factor^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^14th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^14th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^40M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^50M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyrotropin^1st specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyroxine.free^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Tissue polypeptide specific Ag:ACnc:Pt:Urine:Qn


name: Tobramycin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Trichophyton mentagrophytes var interdigitale Ab.IgE:ACnc:Pt:Ser:Qn


name: Triiodothyronine.free^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine.free^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Xylose^1H post dose xylose PO:SCnc:Pt:Ser/Plas:Qn


name: Staphylococcus aureus enterotoxin A Ab.IgE:ACnc:Pt:Ser:Qn


name: Staphylococcus aureus enterotoxin C Ab.IgE:ACnc:Pt:Ser:Qn


name: Staphylococcus aureus enterotoxin D Ab.IgE:ACnc:Pt:Ser:Qn


name: Cancer associated retinopathy Ab:PrThr:Pt:Ser:Ord:IB


name: Herpes simplex virus 1 Ab:Titr:Pt:Ser:SemiQn:IF


name: Herpes simplex virus 1 Ab:Titr:Pt:CSF:SemiQn:IF


name: Herpes simplex virus 2 Ab:Titr:Pt:Ser:SemiQn:IF


name: Herpes simplex virus 2 Ab:Titr:Pt:CSF:SemiQn:IF


name: HIV 2 proviral DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar


name: HIV 2 proviral DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Calcium^pre 500 mg calcium PO:SCnc:Pt:Urine:Qn


name: D-Lactate^1st specimen post exercise:SCnc:Pt:Ser/Plas:Qn


name: D-Lactate^3rd specimen post exercise:SCnc:Pt:Ser/Plas:Qn


name: D-Lactate^4th specimen post exercise:SCnc:Pt:Ser/Plas:Qn


name: D-Lactate^6th specimen post exercise:SCnc:Pt:Ser/Plas:Qn


name: Leptospira borgpetersenii serovar Sejroe Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Lutropin^1st specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^5th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^6th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^8th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Lutropin^9th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:1st IRP


name: Somatotropin^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Thyrotropin^pre dose TRH IN:SCnc:Pt:Ser/Plas:Qn


name: Xylose^2H post dose xylose PO:SCnc:Pt:Ser/Plas:Qn


name: Alkaline phosphatase.other fractions/Alkaline phosphatase.total:CFr:Pt:Ser/Plas:Qn


name: 17-Hydroxycorticosteroids^1D post XXX challenge:SRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post XXX challenge:SRat:24H:Urine:Qn


name: Creatine kinase.macromolecular.type 1/Creatine kinase.total:CFr:Pt:Ser/Plas:Qn


name: Creatine kinase.macromolecular.type 2/Creatine kinase.total:CFr:Pt:Ser/Plas:Qn


name: Extractable nuclear Ab identified:Prid:Pt:Ser:Nom


name: Trichophyton mentagrophytes var goetzii Ab.IgE:ACnc:Pt:Ser:Qn


name: Pyridoxine^pre 250 mg pyridoxine PO:SCnc:Pt:Ser/Plas:Qn


name: Pyridoxine^post 250 mg pyridoxine PO:SCnc:Pt:Ser/Plas:Qn


name: European tick borne encephalitis virus Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: European tick borne encephalitis virus Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: European tick borne encephalitis virus Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: European tick borne encephalitis virus Ab:Titr:Pt:Ser:SemiQn


name: European tick borne encephalitis virus Ab.IgM:ACnc:Pt:Ser:Qn


name: Views^W contrast intra salivary duct:Find:Pt:Head>Salivary gland.left:Doc:RF


name: Views^W contrast intra salivary duct:Find:Pt:Head>Salivary gland.right:Doc:RF


name: Views^W contrast IS:Find:Pt:Lower extremity.bilateral>Hip:Doc:RF


name: Views^W contrast IS:Find:Pt:Lower extremity.left>Hip:Doc:RF


name: Views^W contrast IS:Find:Pt:Lower extremity.right>Hip:Doc:RF


name: Views^W contrast IS:Find:Pt:Lower extremity.left>Knee:Doc:RF


name: Views^W contrast IS:Find:Pt:Lower extremity.right>Knee:Doc:RF


name: Views^W contrast IS:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:RF


name: Views^W contrast IS:Find:Pt:Upper extremity.left>Shoulder:Doc:RF


name: Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries.bilateral:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries.left:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries.right:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:XXX>Spinal artery.bilateral:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:XXX>Spinal artery.left:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:XXX>Spinal artery.right:Doc:RF.angio


name: Views^W radionuclide IV:Find:Pt:Lower extremity.bilateral>Knee:Doc:NM


name: Views^W radionuclide IV:Find:Pt:Lower extremity.right>Knee:Doc:NM


name: Views^W Tc-99m pertechnetate IV:Find:Pt:Pelvis>Scrotum.bilateral+Testicle.bilateral:Doc:NM


name: Views^W Tc-99m pertechnetate IV:Find:Pt:Pelvis>Scrotum.left+Testicle.left:Doc:NM


name: Views^W Tc-99m pertechnetate IV:Find:Pt:Pelvis>Scrotum.right+Testicle.right:Doc:NM


name: Deprecated Femur - bilateral DEXA Bone density


name: Deprecated Femur- left DEXA Bone density


name: Deprecated Femur- right DEXA Bone density


name: Deprecated Radius & Ulna left DEXA Bone density


name: Deprecated Radius & Ulna right DEXA Bone density views


name: View runoff^W contrast IA:Find:Pt:Lower extremity.bilateral>Femoral artery:Doc:RF.angio


name: View runoff^W contrast IA:Find:Pt:Lower extremity.right>Femoral artery:Doc:RF.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Thoracic inlet vessels.bilateral:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Thoracic inlet vessels.right:Doc:MR.angio


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Ankle:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Ankle:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Ankle:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Brachial plexus.left:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Brachial plexus.right:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Elbow:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Elbow:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.right>Elbow:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Thigh:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Thigh:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Thigh:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Knee:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Knee:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Knee:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Shoulder:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.right>Shoulder:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Wrist:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Wrist:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.right>Wrist:Doc:MR


name: Multisection:Find:Pt:Lower extremity.left>Lower extremity joint:Doc:MR


name: Multisection:Find:Pt:Lower extremity.right>Lower extremity joint:Doc:MR


name: Multisection:Find:Pt:Pelvis & Lower extremity.bilateral>Hip:Doc:MR


name: Multisection:Find:Pt:Pelvis & Lower extremity.left>Hip:Doc:MR


name: Multisection:Find:Pt:Pelvis & Lower extremity.right>Hip:Doc:MR


name: Guidance for percutaneous biopsy:Find:Pt:Breast.left:Doc:MG.stereotactic


name: Guidance for percutaneous biopsy:Find:Pt:Breast.right:Doc:MG.stereotactic


name: Guidance for reposition of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.bilateral:Doc:RF.angio


name: Guidance for reposition of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.left:Doc:RF.angio


name: Guidance for atherectomy^W contrast IV:Find:Pt:XXX>Vein.left:Doc:RF.angio


name: Guidance for atherectomy^W contrast IV:Find:Pt:XXX>Vein.right:Doc:RF.angio


name: Guidance for placement of stent:Find:Pt:XXX>Vein.bilateral:Doc:RF.angio


name: Guidance for placement of stent:Find:Pt:XXX>Vein.left:Doc:RF.angio


name: Guidance for placement of peripherally-inserted central venous catheter:Find:Pt:XXX>Vein.left:Doc:RF.angio


name: Guidance for placement of peripherally-inserted central venous catheter:Find:Pt:XXX>Vein.right:Doc:RF.angio


name: Guidance for placement of large bore central venous catheter:Find:Pt:XXX>Vein.bilateral:Doc:{Imaging modality}


name: Guidance for placement of large bore central venous catheter:Find:Pt:XXX>Vein.left:Doc:{Imaging modality}


name: Guidance for placement of large bore central venous catheter:Find:Pt:XXX>Vein.right:Doc:{Imaging modality}


name: Guidance for placement of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.left:Doc:RF.angio


name: Guidance for placement of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.right:Doc:RF.angio


name: Guidance for needle localization:Find:Pt:Breast.bilateral:Doc:US


name: Guidance for needle localization:Find:Pt:Breast.left:Doc:US


name: Guidance for needle localization of mass:Find:Pt:Breast.bilateral:Doc:MG


name: Guidance for needle localization of mass:Find:Pt:Breast.left:Doc:MG


name: Guidance for needle localization of mass:Find:Pt:Breast.right:Doc:MG


name: Guidance for needle localization:Find:Pt:Breast.right:Doc:US


name: Guidance for injection:Find:Pt:Pelvis>Sacroiliac joint.bilateral:Doc:CT


name: Guidance for injection:Find:Pt:Pelvis>Sacroiliac joint.left:Doc:CT


name: Guidance for injection:Find:Pt:Pelvis>Sacroiliac joint.right:Doc:CT


name: Guidance for injection:Find:Pt:XXX>Spine facet joint.bilateral:Doc:RF


name: Guidance for injection:Find:Pt:XXX>Spine facet joint.left:Doc:RF


name: Guidance for injection:Find:Pt:XXX>Spine facet joint.right:Doc:RF


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Extremity.bilateral:Doc:US


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Extremity.left:Doc:US


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Extremity.right:Doc:US


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Abdomen>Kidney.bilateral:Doc:US


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Abdomen>Kidney.left:Doc:US


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Abdomen>Kidney.right:Doc:US


name: Guidance for change of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.bilateral:Doc:RF.angio


name: Guidance for change of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.left:Doc:RF.angio


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.bilateral:Doc:MG


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.left:Doc:MG


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.right:Doc:MG


name: Guidance for percutaneous biopsy:Find:Pt:Breast.bilateral:Doc:MG


name: Guidance for percutaneous biopsy:Find:Pt:Breast.right:Doc:MG


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.bilateral:Doc:US


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.left:Doc:US


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.right:Doc:US


name: Guidance for percutaneous aspiration of cyst:Find:Pt:Breast.left:Doc:MG


name: Guidance for percutaneous aspiration of cyst:Find:Pt:Breast.right:Doc:MG


name: Views bone age:Find:Pt:Upper extremity.bilateral>Wrist+Hand:Doc:XR


name: Views bone age:Find:Pt:Upper extremity.right>Wrist+Hand:Doc:XR


name: View AP^W standing:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: View AP^W standing:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Views AP + PA^W standing:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: Views AP + PA^W standing:Find:Pt:Lower extremity.left>Knee:Doc:XR


name: Views AP + PA^W standing:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Views AP + lateral^W standing:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: Views AP + lateral^W standing:Find:Pt:Lower extremity.left>Knee:Doc:XR


name: Views AP + lateral^W standing:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Guidance for angioplasty^W contrast IA:Find:Pt:Abdomen+Pelvis>Iliac artery.bilateral:Doc:RF.angio


name: Guidance for angioplasty^W contrast IA:Find:Pt:Abdomen+Pelvis>Iliac artery.left:Doc:RF.angio


name: Guidance for angioplasty^W contrast IA:Find:Pt:Abdomen+Pelvis>Iliac artery.right:Doc:RF.angio


name: Administration of vasodilator into catheter:Find:Pt:XXX>Vein.left:Doc


name: Administration of vasodilator into catheter:Find:Pt:XXX>Vein.right:Doc


name: Clinical reports.non lab claims attachment:Complex:-:^Patient:Set


name: lymphocytes:number concentration:point in time:cerebral spinal fluid:quantitative


name: Cortisol.free^24H post dose corticotropin:MCnc:24H:Urine:Qn


name: Cortisol.free^48H post dose corticotropin:MCnc:24H:Urine:Qn


name: Cortisol^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^24H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^32H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^8H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Cortisol^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Glucose^2.5H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^45M post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^3H post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^4H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^5H post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^5H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^6H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^6H post dose glucose:MCnc:Pt:Urine:Qn


name: Glucose^1H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^2H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^30M post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^3H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^4H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^5H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^6H post dose glucose:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^2.5H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^3.5H post dose glucose:MCnc:Pt:Ser/Plas:Qn


name: Trypanosoma brucei gambiense Ab:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis L2 Ab:PrThr:Pt:Ser:Ord


name: Legionella polyvalent A Ab:PrThr:Pt:Ser:Ord


name: Legionella polyvalent B Ab:PrThr:Pt:Ser:Ord


name: Legionella polyvalent C Ab:PrThr:Pt:Ser:Ord


name: Corynebacterium diphtheriae toxin Ab:PrThr:Pt:Ser:Ord


name: Jamestown canyon virus Ab:PrThr:Pt:Ser:Ord


name: Semliki forest virus Ab:PrThr:Pt:Ser:Ord


name: Hantavirus sin nombre Ab.IgM:PrThr:Pt:Ser:Ord


name: Colorado tick fever virus Ab:PrThr:Pt:Ser:Ord


name: Hantavirus sin nombre Ab.IgG:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis D Ab:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis F Ab:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis H Ab:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis I Ab:PrThr:Pt:Ser:Ord


name: Chlamydia trachomatis L1 Ab:PrThr:Pt:Ser:Ord


name: Legionella longbeachae 1 Ab:PrThr:Pt:Ser:Ord


name: Legionella longbeachae 2 Ab:PrThr:Pt:Ser:Ord


name: Western equine encephalitis virus RNA:PrThr:Pt:CSF:Ord:Probe


name: Streptococcus pneumoniae 19 Ab:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 12f Ab:MCnc:Pt:Ser:Qn


name: Glucose^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab.IgG:Titr:Pt:Ser:SemiQn:IA


name: Varicella zoster virus Ab:Titr:Pt:CSF:SemiQn:IF


name: Rhodococcus equi Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Xylose^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Streptococcus pneumoniae Danish serotype 7F Ab:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab:MCnc:Pt:Ser:Qn


name: Myelin associated glycoprotein Ab:PrThr:Pt:Ser:Ord:IA


name: Glucose^1H post dose lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2H post dose lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^5H post dose lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^11H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Eastern equine encephalitis virus RNA:PrThr:Pt:CSF:Ord:Probe


name: Glucose^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Glucose^8th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Amino beta guanidinopropionate:Substance Rate:24 hours:Urine:Quantitative


name: Ketones^3H post XXX challenge:PrThr:Pt:Urine:Ord:Test strip


name: Canine distemper virus Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: Intrinsic factor blocking Ab.IgG:ACnc:Pt:Ser:Qn:RIA


name: Canine distemper virus Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Streptococcus pneumoniae 9 Ab:MCnc:Pt:Ser:Qn (26701-3)


name: Herpes virus 7 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: SCL-70 extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: Xylose^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Xylose^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Xylose^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Xylose^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Neisseria gonorrhoeae Ab:Titr:Pt:CSF:SemiQn:Comp fix


name: Myelin associated glycoprotein Ab.IgM:ACnc:Pt:CSF:Qn


name: Ketones^1H post XXX challenge:PrThr:Pt:Urine:Ord:Test strip


name: Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab:ACnc:Pt:Ser:Qn


name: Ketones^1H post XXX challenge:PrThr:Pt:Urine:Ord


name: Ketones^2H post XXX challenge:PrThr:Pt:Urine:Ord


name: Ketones^3H post XXX challenge:PrThr:Pt:Urine:Ord


name: Herpes simplex virus 2 Ab:ACnc:Pt:CSF:Qn


name: Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab^2nd specimen:MCnc:Pt:Ser:Qn


name: Deprecated Streptococcus pneumoniae 51 IgG Ab [Mass/volume] in Serum


name: Streptococcus pneumoniae Danish serotype 7F Ab^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab^1st specimen:MCnc:Pt:Ser:Qn


name: Herpes virus 6 Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: Herpes virus 6 Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Histoplasma capsulatum mycelial phase Ab:Titr:Pt:CSF:SemiQn:Comp fix


name: Deprecated Protein [Mass/volume] in Serum or Plasma


name: Polio virus Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Histoplasma capsulatum Ab:Titr:Pt:Ser:SemiQn:Immune diffusion


name: Aspergillus flavus Ab:Titr:Pt:Ser:SemiQn:Immune diffusion


name: Aspergillus niger Ab:Titr:Pt:Ser:SemiQn:Immune diffusion


name: Herpes simplex virus 2 Ab.IgG:PrThr:Pt:CSF:Ord


name: Somatotropin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Feline panleukopenia virus Ab.IgM:Titr:Pt:Ser:SemiQn


name: Insulin^1.5H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Feline panleukopenia virus Ab.IgG:Titr:Pt:Ser:SemiQn


name: DOPamine^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estimated average glucose:MCnc:Pt:Bld:Qn:Estimated from glycated hemoglobin


name: DOPamine^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^22nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Chlamydia trachomatis B Ab:Titr:Pt:Ser:SemiQn:IF


name: Chlamydia trachomatis C Ab:Titr:Pt:Ser:SemiQn:IF


name: Chlamydia trachomatis G+F+K Ab:Titr:Pt:Ser:SemiQn:IF


name: Insulin^20M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Streptococcus pneumoniae 12 Ab.IgG:MCnc:Pt:Ser:Qn


name: Aspergillus fumigatus Ab:PrThr:Pt:Body fld:Ord:Immune diffusion


name: Aspergillus flavus Ab:PrThr:Pt:Body fld:Ord:Immune diffusion


name: Insulin^1H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: DOPamine^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Feline herpesvirus 1 Ab:PrThr:Pt:Ser:Ord:IF


name: Blastomyces dermatitidis Ab:PrThr:Pt:Body fld:Ord:Immune diffusion


name: Streptococcus pneumoniae Danish serotype 6B Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 23 Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 19 Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 9 Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 23f Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 12f Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 9n Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae 19f Ab.IgG:MCnc:Pt:Ser:Qn


name: C peptide^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: SCL-70 extractable nuclear Ab:ACnc:Pt:Ser:Qn


name: C peptide^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Streptococcus pneumoniae Danish serotype 7F Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn:IA


name: DOPamine^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^40M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Deprecated Cardiac rehabilitation treatment plan Initial evaluation note (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Plan of treatment (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Reason to continue (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Justification (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Psychiatric symptoms (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Author ID Identifier


name: Deprecated Cardiac rehabilitation treatment plan, End date of hospitalization leading to treatment


name: Deprecated Cardiac rehabilitation treatment plan, Primary diagnosis (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Medication name + identifier Identifier


name: Deprecated Cardiac rehabilitation treatment plan, Medication Dosage


name: Deprecated Cardiac rehabilitation treatment plan, Medication timing + Quantity TQ2


name: Deprecated Cardiac rehabilitation treatment plan, Primary diagnosis Identifier


name: Deprecated Cardiac rehabilitation treatment plan, Diagnosis addressed by plan Identifier


name: Deprecated Cardiac rehabilitation treatment plan, Diagnosis addressed by plan (narrative) Text


name: Deprecated Cardiac rehabilitation treatment plan, Medication route Identifier


name: Deprecated Skilled nursing treatment plan, New/revised


name: Deprecated Skilled nursing treatment plan, Date onset or exacerbation of primary diagnosis


name: Start date:Date:Pt:Skilled nursing treatment plan:Qn


name: Deprecated Clinical discipline - Skilled nursing treatment plan


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, New/revised


name: Start date:Date:Pt:Alcohol-substance abuse rehabilitation treatment plan:Qn


name: Deprecated Clinical discipline - Alcohol-substance abuse rehabilitation treatment plan


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Diagnosis addressed by plan Set


name: Author of treatment plan:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Author name


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Author profession Identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Visit frequency TQ2


name: Deprecated Cardiac rehabilitation treatment plan, New/revised


name: Deprecated Cardiac rehabilitation treatment plan, Date onset or exacerbation of primary diagnosis


name: Start date:Date:Pt:Cardiac rehabilitation treatment plan:Qn


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Visit duration Time


name: Date range (from_through) described by plan:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, End date


name: Date range:Cmplx:Enctr:Hospitalization leading to alcohol-substance abuse rehabilitation treatment:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Continuation status


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date attending MD referred patient for Date


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date rehabilitation professional signed


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Signature of responsible rehabilitation professional on file


name: Deprecated Clinical discipline - Cardiac rehabilitation treatment plan


name: Medication administered:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Prognosis for rehabilitation


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Estimated date of completion Date


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date of last plan of treatment certification


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Past medical history and Level of function (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan Initial evaluation note (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Plan of treatment (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan Progress note and attainment of goals (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Reason to continue (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Justification (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Psychiatric symptoms (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Author ID Identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Start date of hospitalization leading to treatment


name: Deprecated Cardiac rehabilitation treatment plan, Diagnosis addressed by plan Set


name: Author of treatment plan:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan, Author name


name: Deprecated Cardiac rehabilitation treatment plan, Author profession Identifier


name: Deprecated Cardiac rehabilitation treatment plan, Signature date Date and time


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Primary diagnosis (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication name + identifier Identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication Dosage


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication timing + Quantity TQ2


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Primary diagnosis Identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Diagnosis addressed by plan Identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Diagnosis addressed by plan (narrative) Text


name: Deprecated Cardiac rehabilitation treatment plan, Visit frequency TQ2


name: Deprecated Cardiac rehabilitation treatment plan, Visit duration Time


name: Date range (from_through) described by plan:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan, End date


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication route Identifier


name: Deprecated Cardiac rehabilitation treatment plan, Continuation status


name: Deprecated Cardiac rehabilitation treatment plan, Date attending MD referred patient for Date


name: Deprecated Cardiac rehabilitation treatment plan, Date attending MD signed Date and time


name: Deprecated Cardiac rehabilitation treatment plan, Date rehabilitation professional signed


name: Deprecated Cardiac rehabilitation treatment plan, Signature of responsible rehabilitation professional on file


name: Medication administered:Cmplx:Pt:Cardiac rehabilitation treatment:Set


name: Deprecated Cardiac rehabilitation treatment plan, Prognosis for rehabilitation


name: Deprecated Cardiac rehabilitation treatment plan, Estimated date of completion Date


name: Deprecated Cardiac rehabilitation treatment plan, Date of last plan of treatment certification


name: Deprecated Cardiac rehabilitation treatment plan, Past medical history and Level of function (narrative)


name: Deprecated Skilled nursing treatment plan, Diagnosis addressed by plan Set


name: Author of treatment plan:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Deprecated Skilled nursing treatment plan, Author name


name: Deprecated Skilled nursing treatment plan, Author profession Identifier


name: Deprecated Skilled nursing treatment plan, Signature date Date and time


name: Deprecated Skilled nursing treatment plan, Visit frequency TQ2


name: Date range (from_through) described by plan:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Deprecated Skilled nursing treatment plan, End date


name: Date range:Cmplx:Enctr:Hospitalization leading to skilled nursing treatment:Set


name: Deprecated Skilled nursing treatment plan, Continuation status


name: Deprecated Skilled nursing treatment plan, Date attending MD referred patient for Date


name: Deprecated Skilled nursing treatment plan, Date attending MD signed Date and time


name: Deprecated Skilled nursing treatment plan, Date rehabilitation professional signed


name: Deprecated Skilled nursing treatment plan, Signature of responsible attending physician on file


name: Deprecated Skilled nursing treatment plan, Signature of responsible rehabilitation professional on file


name: Medication administered:Cmplx:Pt:Skilled nursing treatment:Set


name: Deprecated Skilled nursing treatment plan, Prognosis for rehabilitation


name: Deprecated Skilled nursing treatment plan, Estimated date of completion Date


name: Deprecated Skilled nursing treatment plan, Date of last plan of treatment certification


name: Deprecated Skilled nursing treatment plan, Past medical history and Level of function (narrative)


name: Deprecated Skilled nursing treatment plan Initial evaluation note (narrative)


name: Deprecated Skilled nursing treatment plan, Plan of treatment (narrative)


name: Deprecated Skilled nursing treatment plan, Reason to continue (narrative)


name: Deprecated Skilled nursing treatment plan, Justification (narrative)


name: Deprecated Skilled nursing treatment plan, Psychiatric symptoms (narrative)


name: Deprecated Skilled nursing treatment plan, Author ID Identifier


name: Deprecated Skilled nursing treatment plan, Start date of hospitalization leading to treatment


name: Deprecated Skilled nursing treatment plan, End date of hospitalization leading to treatment


name: Deprecated Skilled nursing treatment plan, Primary diagnosis (narrative)


name: Deprecated Skilled nursing treatment plan, Medication name + identifier Identifier


name: Deprecated Skilled nursing treatment plan, Medication Dosage